https://www.altheome.com/ https://www.altheome.com/contact https://www.altheome.com/contact-thank-you https://www.altheome.com/capabilities https://www.altheome.com/applications https://www.altheome.com/resources https://www.altheome.com/resources/faqs https://www.altheome.com/resources/data-sheets-and-app-notes https://www.altheome.com/resources/articles-blogs https://www.altheome.com/resources/events https://www.altheome.com/about https://www.altheome.com/capabilities/ultra-sensitive-proteomics/nulisa https://www.altheome.com/capabilities/bioinformatics-data-analysis/bioinformatics-and-data-analysis https://www.altheome.com/capabilities/specialist-sample-metrices/bronchoalveolar-lavage-fluid https://www.altheome.com/capabilities/specialist-sample-metrices/interstitial-fluid https://www.altheome.com/capabilities/specialist-sample-metrices/sputum https://www.altheome.com/capabilities/ultra-sensitive-proteomics/simoa https://www.altheome.com/capabilities/next-generation-sequencing/premade-library-sequencing https://www.altheome.com/capabilities/next-generation-sequencing/ngs-services https://www.altheome.com/capabilities/specialist-sample-metrices/exhaled-breath-condensate https://www.altheome.com/applications/disease-area/dermatology-and-skin-biology https://www.altheome.com/applications/disease-area/oncology https://www.altheome.com/applications/research-area/translational-and-clinical-research https://www.altheome.com/applications/research-area/preclinical-development https://www.altheome.com/applications/research-area/discovery-and-early-research https://www.altheome.com/applications/disease-area/rare-disease-and-precision-medicine https://www.altheome.com/applications/disease-area/neuroscience-and-brain-health https://www.altheome.com/applications/disease-area/respiratory-and-pulmonary-disease https://www.altheome.com/applications/disease-area/immunology-and-inflammation https://www.altheome.com/applications/disease-area/microbiome https://www.altheome.com/applications/disease-area/cardiometabolic-health https://www.altheome.com/applications/disease-area/infectious-disease https://www.altheome.com/applications/disease-area/vaccines-and-immunogenicity https://www.altheome.com/capabilities/specialist-sample-metrices/nasal-lining-fluid https://www.altheome.com/capabilities/specialist-sample-metrices/novel-matrix-validation https://www.altheome.com/capabilities/next-generation-sequencing/metagenomics https://www.altheome.com/capabilities/ultra-sensitive-proteomics/custom-assay-development https://www.altheome.com/capabilities/ultra-sensitive-proteomics/msd https://www.altheome.com/capabilities/next-generation-sequencing/library-preparation-sequencing https://www.altheome.com/about/team https://www.altheome.com/about/careers https://www.altheome.com/about/quality-commitment https://www.altheome.com/cookies https://www.altheome.com/resources/articles-blogs/choosing-the-right-platform-for-your-biomarker-study-when-should-nulisa-simoa-or-msd-be-selected https://www.altheome.com/resources/articles-blogs/more-data-from-less-sample-how-low-volume-workflows-are-changing-biomarker-research https://www.altheome.com/resources/articles-blogs/beyond-a-single-biomarker-exploring-neurological-disease-with-the-nulisaseq%E2%84%A2-neuro-220-panel